Table 1 Patient and tumor characteristics.

From: Usefulness of 3D-surgical guides in breast conserving surgery after neoadjuvant treatment

Total patients (N = 39)

N (%)

Age (yrs)

 ≤ 50

26 (67.7)

 > 50

13 (32.3)

Pathology

Invasive ductal carcinoma

37 (94.9)

Etc

2 (5.1)

Clinical T stage

T1

2 (5.1)

T2

32 (82.1)

T3

5 (12.8)

Clinical N stage

N0

23 (59.0)

N1

13 (33.3)

N2

2 (5.1)

N3

1 (2.6)

Tumor grade

I

0

II

28 (71.8)

III

11 (28.2)

Multifocality (image finding)

Yes

17 (43.6)

No

22 (56.4)

Multifocality (pathologic)

Yes

5 (12.8)

No

34 (87.2)

Subtype

HR(+), HER2(−)

21 (53.8)

HR(+), HER2(+)

5 (12.9)

HR(−), HER2(+)

7 (17.9)

HR(−), HER2(−)

6 (15.4)